Definium Therapeutics Overview
Definium Therapeutics Target Price
Analysts' average 12-month price target for Definium Therapeutics is $66.
Get informed when a big investor buys or sells
+ FollowShare Price
$39.28
Average Target Price
$65.50
66.8% upside
66.8% upside18 analysts in the last 4 months
High: $79 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-15 | Canaccord Genuity | $78 | 98.6% upside |  |
| 2026-09-15 | UBS | $70 | 78.2% upside | |
| 2026-09-15 | Robert W. Baird | $79 | 101.1% upside | |
| 2026-09-14 | Oppenheimer | $75 | 90.9% upside | |
| 2026-08-14 | Maxim Group | $55 | 40% upside | |
| 2026-08-13 | Canaccord GenuitySumant Kulkarni | $64 | 62.9% upside | |
| 2026-08-13 | Robert W. Baird | $75 | 90.9% upside | |
| 2026-08-12 | RBC Capital | $66 | 68% upside | |
| 2026-08-12 | Needham | $66 | 68% upside | |
| 2026-08-12 | Oppenheimer | $70 | 78.2% upside | |
| 2026-07-27 | Wells FargoBenjamin Burnett | $68 | 73.1% upside | |
| 2026-07-24 | Piper Sandler | $73 | 85.8% upside | |
| 2026-07-08 | Stifel Nicolaus | $60 | 52.7% upside | |
| 2026-06-30 | Canaccord Genuity | $58 | 47.7% upside | |
| 2026-06-23 | NeedhamAmi Fadia | $50 | 27.3% upside | |
| 2026-06-22 | Canaccord Genuity | $60 | 52.7% upside | |
| 2026-06-22 | Oppenheimer | $60 | 52.7% upside | |
| 2026-06-22 | Leerink PartnersMarc Goodman | $52 | 32.4% upside | |
| 2026-05-08 | Piper SandlerDavid Amsellem | $48 | 22.2% upside | |
| 2026-04-23 | Oppenheimer | $40 | 1.8% upside | |
| 2026-04-16 | Stifel NicolausPaul Matteis | $30 |  23.6% downside | |
| 2026-04-16 | Canaccord GenuitySumant Kulkarni | $38 | 3.3% downside | |
| 2026-04-10 | Piper Sandler | $49 | 24.7% upside | |
| 2026-02-23 | Wolfe Research | $25 | 36.4% downside | |
| 2026-01-29 | Jefferies | $30 | 23.6% downside | |
| 2026-01-29 | Robert W. Baird | $37 | 5.8% downside | |
| 2026-01-23 | RBC Capital | $36 | 8.4% downside | |
| 2025-10-13 | NeedhamAmi Fadia | $28 | 28.7% downside | |
| 2025-03-07 | Robert W. Baird | $16 | 59.3% downside | |
| 2024-09-16 | Canaccord GenuitySumart Kulkami | $14 | 64.4% downside | |
| 2024-06-05 | RBC CapitalBrian Abrahams | $22 | 44% downside | |
| 2024-05-13 | OppenheimerFrancois Brisebois | $20 | 49.1% downside | |
| 2022-11-16 | RBC Capital | $5 | 87.3% downside | |